ES2188597T3 - Uso de una secuencia genica promotora para el tratamiento de enfermedades reumaticas. - Google Patents

Uso de una secuencia genica promotora para el tratamiento de enfermedades reumaticas.

Info

Publication number
ES2188597T3
ES2188597T3 ES93923675T ES93923675T ES2188597T3 ES 2188597 T3 ES2188597 T3 ES 2188597T3 ES 93923675 T ES93923675 T ES 93923675T ES 93923675 T ES93923675 T ES 93923675T ES 2188597 T3 ES2188597 T3 ES 2188597T3
Authority
ES
Spain
Prior art keywords
treatment
gene sequence
rheumatic diseases
promoting gene
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93923675T
Other languages
English (en)
Inventor
Shunichi Shiozawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2188597T3 publication Critical patent/ES2188597T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UN INHIBIDOR ANTAGONICO CONTRA EL CRECIMIENTO DE CELULAS MESENQUIMALES, QUE SE PUEDE UTILIZAR COMO UN REMEDIO PARA ENFERMEDADES DE COLAGENO TIPIFICADAS POR ARTRITIS REUMATOIDE Y QUE CONTIENEN UN NUCLEOTIDO AP - 1 QUE COMPRENDE TGAGTCA O TGACTCA QUE CONSTITUYEN UN PROMOTOR DE EXPRESION GENICA.
ES93923675T 1993-10-29 1993-10-29 Uso de una secuencia genica promotora para el tratamiento de enfermedades reumaticas. Expired - Lifetime ES2188597T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1993/001581 WO1995011684A1 (en) 1993-10-29 1993-10-29 Antagonistic inhibitor against mesenchymal cell growth

Publications (1)

Publication Number Publication Date
ES2188597T3 true ES2188597T3 (es) 2003-07-01

Family

ID=14070618

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93923675T Expired - Lifetime ES2188597T3 (es) 1993-10-29 1993-10-29 Uso de una secuencia genica promotora para el tratamiento de enfermedades reumaticas.

Country Status (10)

Country Link
EP (1) EP0733370B1 (es)
KR (1) KR100306376B1 (es)
AT (1) ATE232731T1 (es)
AU (1) AU683626B2 (es)
CA (1) CA2175368C (es)
DE (1) DE69332702T2 (es)
DK (1) DK0733370T3 (es)
ES (1) ES2188597T3 (es)
PT (1) PT733370E (es)
WO (1) WO1995011684A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1350514A3 (en) * 1993-10-29 2004-07-07 The Brigham And Women's Hospital, Inc. Therapeutic use of cis-element decoys in vivo
US7615538B2 (en) * 1993-10-29 2009-11-10 Shunichi Shiozawa Method for therapy of rheumatoid arthritis
CA2300328A1 (en) 1999-09-14 2001-03-14 Cardiogene Gentherap. Systeme Ag Modulating transcription of genes in vascular cells
DE29916160U1 (de) 1999-09-14 2000-03-09 Cardiogene Gentherapeutische Systeme AG, 40699 Erkrath Modulation der Transkription von Genen in vaskulären Zellen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006570A1 (en) * 1989-10-25 1991-05-16 The University Of Melbourne HYBRID Fc RECEPTOR MOLECULES
WO1991011535A1 (en) * 1990-01-30 1991-08-08 Childrens Hospital Of Los Angeles Inhibition of transcription by double-stranded oligonucleotides
WO1992007072A1 (en) * 1990-10-10 1992-04-30 La Jolla Cancer Research Foundation Method of inhibiting transcription utilizing nuclear receptors
EP0580754A1 (en) * 1991-04-18 1994-02-02 The Salk Institute For Biological Studies Oligodeoxynucleotides and oligonucleotides useful as decoys for proteins which selectively bind to defined dna sequences
WO1993014768A1 (en) * 1992-01-27 1993-08-05 The Trustees Of The University Of Pennsylvania Methods and compositions for neutralizing intracellular nucleic acid-binding protein biological activity in a cell, including methods and compositions useful to regulate gene function

Also Published As

Publication number Publication date
DE69332702T2 (de) 2003-10-16
DK0733370T3 (da) 2003-04-07
KR960705576A (ko) 1996-11-08
AU683626B2 (en) 1997-11-20
AU5345294A (en) 1995-05-22
CA2175368A1 (en) 1995-05-04
DE69332702D1 (de) 2003-03-27
EP0733370B1 (en) 2003-02-19
ATE232731T1 (de) 2003-03-15
PT733370E (pt) 2003-07-31
EP0733370A1 (en) 1996-09-25
WO1995011684A1 (en) 1995-05-04
CA2175368C (en) 2004-07-20
EP0733370A4 (en) 1999-12-29
KR100306376B1 (ko) 2001-11-30

Similar Documents

Publication Publication Date Title
CY1116385T1 (el) Αντινοηματικη διαμορφωση της εκφρασης της απολιποπρωτεινης β
PT1411118E (pt) Inibidores da proliferação celular contendo um anticorpo anti-glipicano 3
DE69435218D1 (de) Regulation der Genexpression von bcl-2
BR0107942A (pt) Polìmeros de proteìna de liberação lenta
BR9306683A (pt) Adesivo proteináceo curado com aldeído
FI962350A0 (fi) BPM-12, BMP-13 sekä niiden jännettä indusoivat koostumukset
DE69819167D1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
NO873517D0 (no) Forbindelser som er analoge med vevplasminogenaktivator.
DE69023698D1 (de) Hochfrequenzverstärker mit Optimierung des Stromverbrauches.
FI902448A7 (fi) Kulutusta kestäviä materiaaleja, joilla on suuri kovuus
AR021695A1 (es) 4,5-pirazinoxindoles, composicion farmaceutica y uso
DE69328025D1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
ES2188597T3 (es) Uso de una secuencia genica promotora para el tratamiento de enfermedades reumaticas.
DE69013458D1 (de) Plasmide und Wirtszellen zur Expression von INA Protein (Ice nucleating protein).
DK0734380T3 (da) 4-Benzoylisoxazoler samt deres anvendelse som herbicider
DE50101861D1 (de) Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung
DE50009838D1 (de) Humanes antibiotisches protein
AR011110A1 (es) Promotor del gen de endoglina humana, una construccion de acido nucleico que comprende al menos una secuencia promotora del gen de endoglina humana, unacelula que alberga dicha construccion de acido nucleico, y el uso de dicha construccion de acido nucleico para preparar un farmaco
ES2136199T3 (es) Expresion multicistronica de genes recombinantes en celulas bacterianas.
DE69736325D1 (de) Cr1 fragmente und deren verwendung
ATE334215T1 (de) Verwendung des aminoglycosidresistenzgens
ES1008313Y (es) Clavo intramedular para el tratamiento de fracturas de huesos largos.
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi
ES1004548Y (es) Bandeja de letras moviles para el aprendizaje de la escritura.